Presentation THT 2026 Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy Presenter: Thitiphan Srikulmontri March 03, 2026 REGISTER for free or LOG IN to view this content THT 2026 Up Next Presentation THT 2026 Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER Presenter: Thitiphan Srikulmontri March 03, 2026 More slides + Presentation THT 2026 Echocardiographic Assessment of Pulmonary Vascular Resistance Changes and Clinical Outcomes Following Transcatheter Mitral Valve Edge-to-Edge Repair Presenter: Frailyn J. Nunez March 03, 2026 Presentation THT 2026 Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis Presenter: Hanna Gaggin March 03, 2026 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation THT 2026 Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER Presenter: Thitiphan Srikulmontri March 03, 2026
Presentation THT 2026 Echocardiographic Assessment of Pulmonary Vascular Resistance Changes and Clinical Outcomes Following Transcatheter Mitral Valve Edge-to-Edge Repair Presenter: Frailyn J. Nunez March 03, 2026
Presentation THT 2026 Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis Presenter: Hanna Gaggin March 03, 2026